Company Name: Achaogen, Inc.

Achaogen, Inc. is a clinical stage biopharmaceutical company.  The company is engaged in the development and commercialization of antibacterials for multidrug resistant (MDR) gram-negative infections.

Ticker Symbol: AKAO (NASDAQ)

Company Website: www.achaogen.com

Social Media: Achaogen LinkedIn

Headquarters: South San Francisco, CA